Fluorescent detection of lipid peroxidation derived protein adducts upon in-vitro cigarette smoke exposure

References

• Ballaz S, Mulshine JL. 2003. The potential contributions of chronic inflammation to lung carcinogenesis. Clin Lung Cancer 5:46–62.
   PubMedGoogle Scholar
• Berrieman HK, Ashman JN, Cowen ME, Greenman J, Lind MJ, Cawkwell L. 2004. Chromosomal analysis of non-small-cell lung cancer by multicolour fluorescent in situ hybridisation. Br J Cancer 90:900–905.
   PubMedGoogle Scholar
• Bluhm AL, Weinstein J, Sousa JA. 1971. Free radicals in tobacco smoke. Nature 229:500.
   PubMed Web of Science ®Google Scholar
• Bolgar MS, Yang CY, Gaskell SJ. 1996. First direct evidence for lipid/protein conjugation in oxidized human low density lipoprotein. J Biol Chem 271:27999–28001.
   PubMed Web of Science ®Google Scholar
• Carbone DL, Doorn JA, Kiebler Z, Ickes BR, Petersen DR. 2005. Modification of heat shock protein 90 by 4-hydroxynonenal in a rat model of chronic alcoholic liver disease. J Pharmacol Exp Ther 315:8–15.
   PubMed Web of Science ®Google Scholar
• Centers for Disease Control and Prevention. 2004. Percentage distribution of adult current smokers, by number of cigarettes smoked per day, and percentage of adult current cigarette smokers who smoked > 25 cigarettes per day, by sex, race, Hispanic origin, age, and education. National Health Surveys - Selected Years - United States, 1974–2000.
   Google Scholar
• Chen PX, Modoveanu CS. 2003. Mainstream smoke chemical analysis for 2R4F Kentucky reference cigarette. Beitrage zur Tabakforschung 20:448–458.
   Google Scholar
• Church DF, Pryor WA. 1985. Free-radical chemistry of cigarette smoke and its toxicological implications. Environ Health Perspect 64:111–126.
   PubMed Web of Science ®Google Scholar
• Crabb JW, O’Neil J, Miyagi M, West K, Hoff HF. 2002. Hydroxynonenal inactivates cathepsin B by forming Michael adducts with active site residues. Protein Sci 11:831–840.
   PubMedGoogle Scholar
• Doorn JA, Petersen DR. 2002. Covalent modification of amino acid nucleophiles by the lipid peroxidation products 4-hydroxy-2-nonenal and 4-oxo-2-nonenal. Chem Res Toxicol 15:1445–1450.
   PubMed Web of Science ®Google Scholar
• Feng Z, Hu W, Tang MS. 2004. Trans-4-hydroxy-2-nonenal inhibits nucleotide excision repair in human cells: a possible mechanism for lipid peroxidation-induced carcinogenesis. Proc Natl Acad Sci USA 101:8598–8602.
   PubMed Web of Science ®Google Scholar
• Gackowski D, Kowalewski J, Siomek A, Olinski R. 2005. Oxidative DNA damage and antioxidant vitamin level: comparison among lung cancer patients, healthy smokers and nonsmokers. Int J Cancer 114:153–156.
   PubMed Web of Science ®Google Scholar
• Gard AL, Solodushko VG, Waeg G, Majic T. 2001. 4-Hydroxynonenal, a lipid peroxidation byproduct of spinal cord injury, is cytotoxic for oligodendrocyte progenitors and inhibits their responsiveness to PDGF. Microsc Res Tech 52:709–718.
   PubMedGoogle Scholar
• Isom AL, Barnes S, Wilson L, Kirk M, Coward L, Darley-Usmar V. 2004. Modification of Cytochrome c by 4-hydroxy- 2-nonenal: evidence for histidine, lysine, and arginine-aldehyde adducts. J Am Soc Mass Spectrom 15:1136–1147.
   PubMed Web of Science ®Google Scholar
• Itakura K, Osawa T, Uchida K. 1998. Structure of a fluorescent compound formed from 4-hydroxy-2-nonenal and N(alpha)-hippuryllysine: a model for fluorophores derived from protein modifications by lipid peroxidation. J Org Chem 63:185–187.
   PubMed Web of Science ®Google Scholar
• Kuo CL, Vaz AD, Coon MJ. 1997. Metabolic activation of trans-4-hydroxy-2-nonenal, a toxic product of membrane lipid peroxidation and inhibitor of P450 cytochromes. J Biol Chem 272:22611–22616.
   PubMed Web of Science ®Google Scholar
• Liu Z, Minkler PE, Sayre LM. 2003. Mass spectroscopic characterization of protein modification by 4-hydroxy-2-(E)-nonenal and 4-oxo-2-(E)-nonenal. Chem Res Toxicol 16:901–911.
   PubMed Web of Science ®Google Scholar
• Maselli R, Grembiale RD, Pelaia G, Cuda G. 2002. Oxidative stress and lung diseases. Monaldi Arch Chest Dis 57:180–181.
   PubMedGoogle Scholar
• Muscat JE, Kleinman W, Colosimo S, Muir A, Lazarus P, Park J, Richie JP, Jr. 2004. Enhanced protein glutathiolation and oxidative stress in cigarette smokers. Free Radic Biol Med 36:464–470.
   PubMed Web of Science ®Google Scholar
• Pryor WA. 1997. Cigarette smoke radicals and the role of free radicals in chemical carcinogenicity. Environ Health Perspect 105 (Suppl 4):875–882.
   PubMedGoogle Scholar
• Rahman I, Morrison D, Donaldson K, MacNee W. 1996. Systemic oxidative stress in asthma, COPD, and smokers. Am J Respir Crit Care Med 154:1055–1060.
   PubMed Web of Science ®Google Scholar
• Rodgman A, Green CR. 2003. Toxic chemicals in cigarette mainstream smoke—hazard and hoopla. Beitrage zur Tabakforschung 20:481–545.
   Google Scholar
• Schneider C, Tallman KA, Porter NA, Brash AR. 2001. Two distinct pathways of formation of 4-hydroxynonenal. Mechanisms of nonenzymatic transformation of the 9- and 13-hydroperoxides of linoleic acid to 4-hydroxyalkenals. J Biol Chem 276:20831–20838.
   PubMed Web of Science ®Google Scholar
• Szweda LI, Uchida K, Tsai L, Stadtman ER. 1993. Inactivation of glucose-6-phosphate dehydrogenase by 4-hydroxy-2-nonenal. Selective modification of an active-site lysine. J Biol Chem 268:3342–3347.
   PubMed Web of Science ®Google Scholar
• Tonon G, Wong KK, Maulik G, Brennan C, Feng B, Zhang Y, Khatry DB, Protopopov A, You MJ, Aguirre AJ, Martin ES, Yang Z, Ji H, Chin L, Depinho RA. 2005. High-resolution genomic profiles of human lung cancer. Proc Natl Acad Sci USA 102:9625–9630.
   PubMed Web of Science ®Google Scholar
• Traverso N, Menini S, Cosso L, Odetti P, Albano E, Pronzato MA, Marinari UM. 1998. Immunological evidence for increased oxidative stress in diabetic rats. Diabetologia 41:265–270.
   PubMedGoogle Scholar
• Tsai L, Szweda PA, Vinogradova O, Szweda LI. 1998. Structural characterization and immunochemical detection of a fluorophore derived from 4-hydroxy-2-nonenal and lysine. Proc Natl Acad Sci USA 95:7975–7980.
   PubMed Web of Science ®Google Scholar
• Uchida K. 2003. 4-Hydroxy-2-nonenal: a product and mediator of oxidative stress. Prog Lipid Res 42:318–343.
   PubMed Web of Science ®Google Scholar
• Uchida K, Itakura K, Kawakishi S, Hiai H, Toyokuni S, Stadtman ER. 1995. Characterization of epitopes recognized by 4-hydroxy-2-nonenal specific antibodies. Arch Biochem Biophys 324:241–248.
   PubMed Web of Science ®Google Scholar
• Uchida K, Kanematsu M, Morimitsu Y, Osawa T, Noguchi N, Niki E. 1998. Acrolein is a product of lipid peroxidation reaction. Formation of free acrolein and its conjugate with lysine residues in oxidized low density lipoproteins. J Biol Chem 273:16058–16066.
   PubMed Web of Science ®Google Scholar
• van der Vaart H, Postma DS, Timens W, ten Hacken NH. 2004. Acute effects of cigarette smoke on inflammation and oxidative stress: a review. Thorax 59:713–721.
   PubMed Web of Science ®Google Scholar
• West JD, Ji C, Duncan ST, Amarnath V, Schneider C, Rizzo CJ, Brash AR, Marnett LJ. 2004. Induction of apoptosis in colorectal carcinoma cells treated with 4-hydroxy-2-nonenal and structurally related aldehydic products of lipid peroxidation. Chem Res Toxicol 17:453–462.
   PubMed Web of Science ®Google Scholar
• West JD, Marnett LJ. 2005. Alterations in gene expression induced by the lipid peroxidation product, 4-hydroxy-2-nonenal. Chem Res Toxicol 18:1642–53.
   PubMed Web of Science ®Google Scholar
• West JD, Marnett LJ. 2006. Endogenous reactive intermediates as modulators of cell signaling and cell death. Chem Res Toxicol 19:173–194.
   PubMed Web of Science ®Google Scholar
• Yla-Herttuala S, Palinski W, Rosenfeld ME, Parthasarathy S, Carew TE, Butler S, Witztum JL, Steinberg D. 1989. Evidence for the presence of oxidatively modified low density lipoprotein in atherosclerotic lesions of rabbit and man. J Clin Invest 84:1086–95.
   PubMed Web of Science ®Google Scholar